Free Newsletter
Bloomberg: Japan got Seroquel warning before U.S.
Bloomberg has been hot on the trail of the Seroquel litigation, and in its latest foray into newly unsealed documents, found that AstraZeneca in 2002 warned Japanese doctors of diabetes cases in Seroquel patients "where causality with the drug could not be ruled out." Similar U.S. warnings did not come until 2004, the news service states. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
SHARE
WITH: